U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

The FDA Drug Shortage database is currently experiencing technical difficulties and some of the information contained in the database may not reflect the current supply status.

Start Over | Back to Search Results

Dextrose 50% Injection
Status: Currently in Shortage
»Date first posted: 01/13/2022
»Therapeutic Categories: Endocrinology/Metabolism; Gastroenterology; Pediatric

Expand all

Amphastar Pharmaceuticals, Inc./IMS (Reverified 08/12/2022)

Company Contact Information:
800-423-4136

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
25 g/50 mL (0.5 g/mL), syringe, 10 per carton (NDC 76329-3302-1) (old NDC 76329-3301-1) Backorder due to increase in demand Demand increase for the drug

Hospira, Inc. (Revised 07/01/2022)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
25 g/50 mL (0.5 g/mL), plastic syringe, 10 per bundle (NDC 0409-7517-16) Next Delivery: June 2022; Estimated Recovery: January 2023

Pfizer Customer Letter dated March 4, 2022.

Other
25 g/50 mL (0.5 g/mL), glass syringe, 10 per bundle (NDC 0409-4902-34) Next Delivery: July 2022; Estimated Recovery: January 2023

Pfizer Customer Letter dated March 4, 2022.

Other
25 g/50 mL (0.5 g/mL), single dose vial, 25 per tray (NDC 0409-6648-02) Next Delivery: July 2022; Estimated Recovery: March 2023 Other
Back to Top